Literature DB >> 24880990

Comparison of posterior capsule opacification in rabbit eyes receiving different administrations of rapamycin.

Hongling Liu1, Yanyan Zhang, Haiyan Ma, Chunmei Zhang, Shaoying Fu.   

Abstract

BACKGROUND: Posterior capsule opacification (PCO) is a common complication after cataract surgery. The purpose of this study was to determine the effects of three administering ways of rapamycin (RAPA) on the formation of PCO in rabbit eyes for 12 weeks.
METHODS: Eighty rabbits were divided into four groups, according to the different administrations of RAPA which they received. These were: (1) the control group, (2) the irrigation-treated group - 5 ng/ml intraoperative RAPA irrigation solution, (3) the eye-drop-treated group - 2 mg/ml RAPA eye drops, and (4) the IOL-treated group - RAPA-poly(lactic-co-glycolic) acid (PLGA) loaded on the surface of intraocular lens (IOLs) (RAPA-PLGA-IOLs). All right eyes were treated with lens extraction plus IOL implantation, receiving relative administrations of RAPA. RAPA concentrations in the aqueous humour were determined by high performance of liquid chromatography (HPLC). The anterior chamber (AC) response was observed through slit-lamp biomicroscopy. After 12 weeks, the degree of PCO was determined by clinical evaluation. The histological sections, immunohistochemistry expression of proliferating cell nuclear antigen (PCNA) in the lens capsule were conducted.
RESULTS: In the early period, AC response for both experimental and control eyes were similar. In the IOL-treated group, RAPA reached its peak at 25.68 ± 0.74 μg/ml on the 4th day, and it was detectable until 8 weeks afterwards. However, in the other groups, RAPA could not be detected all the time. Compared with other groups, in the IOL-treated group, PCO was greatly alleviated; only a few layers of the lens epithelial cells (LECs) and a little proliferative material around the posterior capsules, and a significantly weak expression of PCNA in the nuclei of LECs. By contrast, there was no significant statistical difference in eye-drop-treated or irrigation-treated eyes and control eyes respectively.
CONCLUSIONS: Intraocular RAPA-PLGA-IOL was a promising, effective, and safe administration to prevent PCO compared with other methods in the rabbit PCO model.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24880990     DOI: 10.1007/s00417-014-2656-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

Review 1.  From beach to bedside: history of the development of sirolimus.

Authors:  K L Napoli; P J Taylor
Journal:  Ther Drug Monit       Date:  2001-10       Impact factor: 3.681

2.  The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment.

Authors:  Y Wang; V M Wang; C-C Chan
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

Review 3.  Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.

Authors:  S N Sehgal
Journal:  Clin Biochem       Date:  1998-07       Impact factor: 3.281

Review 4.  Sirolimus: a comprehensive review.

Authors:  B D Kahan
Journal:  Expert Opin Pharmacother       Date:  2001-11       Impact factor: 3.889

5.  The Auckland Cataract Study: 2 year postoperative assessment of aspects of clinical, visual, corneal topographic and satisfaction outcomes.

Authors:  A M Thompson; N Sachdev; T Wong; A F Riley; C N Grupcheva; C N McGhee
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

6.  Hepatocyte growth factor induces proliferation of lens epithelial cells through activation of ERK1/2 and JNK/SAPK.

Authors:  Jongkyu Choi; Sun Young Park; Choun-Ki Joo
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

7.  Polylactide-glycoli acid and rapamycin coating intraocular lens prevent posterior capsular opacification in rabbit eyes.

Authors:  Hongling Liu; Lan Wu; Shaoying Fu; Yongsheng Hou; Ping Liu; Hao Cui; Jingjing Liu; Lin Xing; Xiaomei Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-09       Impact factor: 3.117

8.  Evaluation of neodymium:yttrium-aluminum-garnet capsulotomies in eyes implanted with AcrySof intraocular lenses.

Authors:  Josef M Schmidbauer; Luis G Vargas; David J Apple; Marcela Escobar-Gomez; Andrea Izak; Stella N Arthur; Ariadne Golescu; Qun Peng
Journal:  Ophthalmology       Date:  2002-08       Impact factor: 12.079

9.  The effects of rapamycin on lens epithelial cell proliferation, migration, and matrix formation: an in vitro study.

Authors:  Hongling Liu; Guangzhong Feng; Lan Wu; Shaoying Fu; Ping Liu; Wei Yang; Xiaomei Zhang
Journal:  Mol Vis       Date:  2010-08-16       Impact factor: 2.367

10.  Anti-proliferation effects of Sirolimus sustained delivery film in rabbit glaucoma filtration surgery.

Authors:  Zhi-chao Yan; Yu-jing Bai; Zhen Tian; Hai-yan Hu; Xiu-hua You; Jian-xian Lin; Shao-rui Liu; Ye-hong Zhuo; Rong-jiang Luo
Journal:  Mol Vis       Date:  2011-09-27       Impact factor: 2.367

View more
  4 in total

1.  Local application of rapamycin reduces epidural fibrosis after laminectomy via inhibiting fibroblast proliferation and prompting apoptosis.

Authors:  Yu Sun; Shuai Zhao; Xiaolei Li; Lianqi Yan; Jingcheng Wang; Daxin Wang; Hui Chen; Jihang Dai; Jun He
Journal:  J Orthop Surg Res       Date:  2016-05-06       Impact factor: 2.359

Review 2.  Research Progress of Drug Prophylaxis for Lens Capsule Opacification after Cataract Surgery.

Authors:  Rong-Pei Zhang; Zheng-Gao Xie
Journal:  J Ophthalmol       Date:  2020-07-04       Impact factor: 1.909

Review 3.  Therapeutic Ophthalmic Lenses: A Review.

Authors:  N Toffoletto; B Saramago; A P Serro
Journal:  Pharmaceutics       Date:  2020-12-28       Impact factor: 6.321

Review 4.  Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification.

Authors:  Yidong Zhang; Chengshou Zhang; Silong Chen; Jianghua Hu; Lifang Shen; Yibo Yu
Journal:  Pharmaceutics       Date:  2022-06-25       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.